GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL21 processing
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ULTA · Apr 30, 2016

Ulta Beauty, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001193125-16-611186General Corporate
Capex intensity0thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

5.06% · OPTIONAL · VALID

Revenue growth88thOwn-history percentile · N=16
Evidence method

Yoy · gp.fundamentals.revenue

23.68% · CORE · VALID

Gross margin80thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

36.36% · CORE · VALID

Operating margin100thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

13.71% · CORE · VALID

SBC intensity0thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

0.37% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History62 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
7.62%
Current
5.06%
Delta
-2.56%
Growth Increased
Previous
21.06%
Current
23.68%
Delta
2.62%
Margin Increased
Previous
35.28%
Current
36.36%
Delta
1.08%
Profitability Increased
Previous
12.90%
Current
13.71%
Delta
0.80%
Sbc Intensity Decreased
Previous
0.40%
Current
0.37%
Delta
-0.02%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.